SLC26A3 and Hyperoxaluria: To date, no studies have confirmed the role of SLC26A3 in renal physiology, but its role in the regulation of enteric anion exchange suggests that targeting SLC26A3 may represent a novel strategy to prevent CaOx urolithiasis, as it regulates oxalic acid metabolism in the body to reduce the risk of kidney stones caused by hyperoxaluria.